AGRN anticorps

N° du produit ABIN2426533

Détail du produit anti-AGRN anticorps

Antigène: AGRN (Agrin (AGRN))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp AGRN est non-conjugé

Application: Immunohistochemistry (IHC), ELISA

Purification: Affinity purification

Immunogène: Synthetic peptide of human AGRN

Isotype: IgG

Information d'application

Indications d'application: IHC 1:50-1:200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.3 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Agent conservateur: Sodium azide

Conseil sur la manipulation: Avoid freeze / thaw cycles.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur AGRN

Antigène: AGRN (Agrin (AGRN))

Autre désignation: AGRN (AGRN Produits)

Synonymes: anticorps AGRIN, anticorps agrn, anticorps wu:fb57e07, anticorps Agrin, anticorps nmf380, anticorps AGR, anticorps HSPG, anticorps agrin, anticorps LOC465392, anticorps agrn, anticorps AGRN, anticorps Agrn

Sujet: AGRIN,Agrin proteoglycan,AGRN,FLJ45064,OTTHUMP00000044043,This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found.

NCBI Accession: NP_940978

Pathways: Glycosaminoglycan Metabolic Process, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development